RT Journal Article
SR Electronic
T1 Risk factors for increased COVID-19 case-fatality in the United States: A county-level analysis during the first wave
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.24.21252135
DO 10.1101/2021.02.24.21252135
A1 Millar, Jess A.
A1 Dao, Hanh Dung N.
A1 Stefopulos, Marianne E.
A1 Estevam, Camila G.
A1 Fagan-Garcia, Katharine
A1 Taft, Diana H.
A1 Park, Christopher
A1 Alruwaily, Amaal
A1 Desai, Angel N.
A1 Majumder, Maimuna S.
YR 2021
UL http://medrxiv.org/content/early/2021/02/26/2021.02.24.21252135.abstract
AB The ongoing COVID-19 pandemic is causing significant morbidity and mortality across the US. In this ecological study, we identified county-level variables associated with the COVID-19 case-fatality rate (CFR) using publicly available datasets and a negative binomial generalized linear model. Variables associated with decreased CFR included a greater number of hospitals per 10,000 people, banning religious gatherings, a higher percentage of people living in mobile homes, and a higher percentage of uninsured people. Variables associated with increased CFR included a higher percentage of the population over age 65, a higher percentage of Black or African Americans, a higher asthma prevalence, and a greater number of hospitals in a county. By identifying factors that are associated with COVID-19 CFR in US counties, we hope to help officials target public health interventions and healthcare resources to locations that are at increased risk of COVID-19 fatalities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementJAM is supported by a grant from the National Science Foundation GRFP (DGE-1256260) and through the Rackham Merit Fellowship through the University of Michigan. HDD is supported by the Hudson Fellows in Public Health program through the University of Oklahoma Health Sciences Center. CGE is supported by the Coordenação de Aperfeiçoamento de Pessoal de Nável Superior - Brasil (CAPES) - Finance Code 001- through the State University of Campinas. DHT is supported by a post-doctoral fellowship from NICHD (1F32HD093185-03). AND is supported in part by a grant from the International Society for Infectious Diseases. MSM is supported by a grant (T32HD040128) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Human data used was taken from publicly available data sets.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used was taken from publicly available data sets. The list of these data sets can be found in Appendix A3.